Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

5 treatments under study, led by Thoracoscopic Laa Clipping

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

3Total
Not Applicable (3)

Trial Status

Active Not Recruiting1
Recruiting1
Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (3)

Showing 3 of 3 trials
NCT07541989Not ApplicableActive Not RecruitingPrimary

Pulsed-Field Ablation With/Without Electrogram Mapping

NCT06021808Not ApplicableRecruitingPrimary

LAA Clipping Versus NOACs to Prevent Stroke in Non-paroxysmal Atrial Fibrillation.

NCT02656537Not ApplicableCompletedPrimary

EnSite™ HD Grid Catheter AF/AT Mapping Study

Showing all 3 trials

Research Network

Common Treatments

  • Thoracoscopic Laa Clipping1
  • Novel Oral Anticoagulant1
  • Pfabased Pvipwi Alone1
  • Pfabased Pvipwi Plus Adjunctive Ablation Guided By Electrogram Mapping Of Key Substrates1
  • Ensite Hd Grid Catheter Mapping System1

Active Sponsors

  • Shanghai Chest Hospital of Shanghai Jiao Tong University1
  • Abbott Medical Devices1
  • China National Center for Cardiovascular Diseases1
  • Xu Liu1

Top Investigators

Related Conditions

  • Left Atrial Tachycardia1

Activity Timeline